Moneycontrol
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Dr Reddys Laboratories

Dr Reddys Laboratories

BSE: 500124|NSE: DRREDDY|ISIN: INE089A01023|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Oct 19, 19:50
2388.00
3.25 (0.14%)
VOLUME 2,672
LIVE
NSE
Oct 19, 19:45
2373.05
-12.35 (-0.52%)
VOLUME 47,303
News on Dr Reddys Laboratories
Select Year: 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Dr Reddy's Laboratories recalls Famotidine tablets from US market

2.45 pm | 20 Oct 2017 |  Source: PTI

According to a notification put up by the US Food and Drug Administration, the recall is being made under 'Class-III' classification, which is...

Dr Reddys Labs Q2 PAT seen up 4.7% YoY to Rs. 308.8 cr: Kotak

5.57 pm | 13 Oct 2017 |  Source: Moneycontrol.com

Net Sales are expected to increase by 5.6 percent Y-o-Y (up 14.2 percent Q-o-Q) to Rs. 3787.8 crore, according to Kotak....

Dr Reddy's Lab rises 4% on launch of kidney drug in US market

9.58 am | 03 Oct 2017 |  Source: Moneycontrol.com

This is the company’s eight overall and fourth limited competition launch this fiscal year....

DRL launches Renvela generic in US, price target at Rs 2200: HDFC Securities 

9.16 am | 03 Oct 2017 |  Source: CNBC-TV18

The pharma major Dr Reddys Laboratories (DRL) has launched kidney disease drug Renvela generic in the US market. How big an opportunity can this be fo...

News LIVE: BJP President Amit Shah urges an end to communism in India

7.04 am | 03 Oct 2017 |  Source: Moneycontrol.com

This blog will keep track of key global and local developments impacting business and markets through the day....

Dr Reddy's Laboratories launches Sevelamer Carbonate Tablets

1.48 pm | 02 Oct 2017 |  Source: Moneycontrol.com

Dr. Reddy's Laboratories has launched Sevelamer Carbonate Tablets 800 mg in the US Market....

Dr Reddy's launches Sevelamer Carbonate tablets in US 

4.03 pm | 30 Sep 2017 |  Source: Moneycontrol.com

Dr Reddy's Laboratories has launched Sevelamer Carbonate tablets (generic version of Renvela) in the US market....

Dr Reddy's Laboratories may move to Rs 2600-2650: Ashwani Gujral

4.02 pm | 28 Sep 2017 |  Source: CNBC-TV18

Ashwani Gujral of ashwanigujral.com feels that Dr Reddy's Laboratories maybe you can get still Rs 2,600-2,650....

Dr Reddy's gets EIR from USFDA for Srikakulam unit

12.31 pm | 28 Sep 2017 |  Source: PTI

"With regard to the audit of the company's formulation Srikakulam Plant (SEZ) Unit I, Andhra Pradesh...the company have received an EIR from the U...

Dr Reddys Labs rallies 4% on EIR report from USFDA for Srikakulam plant unit 1 

11.33 am | 28 Sep 2017 |  Source: Moneycontrol.com

The pharma major today informed exchanges that it has received establishment inspection report from the US Food and Drug Administration for Srikakulam...

News Live: Don't have luxury of being former FM-turned-columnist, says Jaitley

7.05 am | 28 Sep 2017 |  Source: Moneycontrol.com

Speaking at an event, the finance minister said that there is a unique divergence emerging in India, which was not there previously....

Pharma stocks extend gains, Divis & Dr Reddy's get reprieve from US FDA

5.36 pm | 23 Sep 2017 |  Source: Moneycontrol.com

Pharma stocks extended their gain this week on the back of sustained investor interest in the sector owing to attractive valuations....

Regulatory issues should reduce going ahead for DRL: Edelweiss Sec 

2.20 pm | 22 Sep 2017 |  Source: CNBC-TV18

Pharma stocks have been on an upward trend. In an interview to CNBC-TV18, Deepak Malik, Pharma Analyst of Edelweiss Securities discussed what is happe...

Buy Dr Reddys Laboratories; target of Rs 3500: Edelweiss

11.42 am | 22 Sep 2017 |  Source: Moneycontrol.com

Edelweiss is bullish on Dr Reddys Laboratories has recommended buy rating on the stock with a target price of Rs 3500 in its research report dated Sep...

Dr Reddy's gets EIR for 2 facilities

1.47 pm | 21 Sep 2017 |  Source: PTI

The company has received EIR from the United States Food and Drug Administration (USFDA) for its formulations manufacturing facility at Srikakulam uni...

Positive sentiment for pharma stocks lifts Cipla 4%; UBS maintains buy

1.46 pm | 21 Sep 2017 |  Source: Moneycontrol.com

"Cipla is our top pick in the sector given high branded generic exposure," UBS said....

Top buzzing midcap stocks to trade on September 21 

1.06 pm | 21 Sep 2017 |  Source: CNBC-TV18

Here are a few top buzzing midcap stocks picked by CNBC-TV18's analysts in trade today -- Dr Reddys, NBCC, Divis Laboratories, Dishman Pharma, Las...

Dr Reddy’s Laboratories receives EIR from USFDA

10.53 am | 21 Sep 2017 |  Source: Moneycontrol.com

Dr Reddy’s Laboratories has received an establishment inspection report (EIR) from the US Food and Drug Administration, for Formulation Srikakulam P...

Upbeat CLSA view, procedural observations from US FDA send DRL stock up 3%

12.38 pm | 20 Sep 2017 |  Source: Moneycontrol.com

The global broking firm also observed that three products, Nuvaring, Suboxone & Copaxone will be major contributors over FY19-20. In fact, the EPS for...

Buy, Sell, Hold: 4 sectors and 2 sectors are on analysts’ radar today

9.06 am | 14 Sep 2017 |  Source: CNBC-TV18

Sun Pharma, Jubilant Foodworks and OMCs are being tracked by investors on Thursday....

1 2 3 4 5
Quick Links for Dr Reddys Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.